Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
The iCaReMe Global Registry is a clinical trial aimed at gathering important information about patients with type 2 diabetes, hypertension (high blood pressure), chronic kidney disease, and heart failure. The goal is to understand how these conditions are managed in everyday life, how often patients visit healthcare providers, and what health outcomes they experience. This study will help improve care for people living with these conditions.
To participate in this registry, you need to be at least 18 years old and have one or more of the conditions mentioned above. You will need to provide your consent, which means you agree to join the study and understand what it involves. It's important to know that if you have a serious health issue that might limit your life expectancy to less than a year, or if you are already part of another trial, you won't be eligible to join this one. Participants can expect to share their health information, which will contribute to a better understanding of how to manage these diseases effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Being 18 years or older
- • 2. Having type 2 diabetes, Hypertension, Heart Failure and/or chronic kidney disease
- • 3. Providing written informed consent to participate in the registry
- Exclusion Criteria:
- • 1. Having a life-threatening co-morbidity with life expectancy below 1 year
- • 2. Participating in an interventional trial requiring informed consent
About Astrazeneca
AstraZeneca is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative medicines across various therapeutic areas, including oncology, cardiovascular, respiratory, and autoimmune diseases. With a strong commitment to scientific research and patient-centric solutions, AstraZeneca leverages cutting-edge technology and a robust pipeline to address unmet medical needs. The company collaborates with healthcare professionals, academic institutions, and other organizations to advance clinical trials and deliver transformative therapies, aiming to improve health outcomes and enhance the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taichung, , Taiwan
Taipei, , Taiwan
Kuala Lumpur, , Malaysia
Ahmedabad, , India
Guadalajara, Jalisco, Mexico
Larissa, , Greece
Chihuahua, , Mexico
São Paulo, , Brazil
Lima, , Peru
Campina Grande Do Sul, Paraná, Brazil
Parow, , South Africa
Sharjah, , United Arab Emirates
San Juan Del Rio, Queretaro, Mexico
Pune, Maharashtra, India
Tainan City, , Taiwan
San Jose, Los Yoses, San Pedro, Costa Rica
Fleming, Alexandria, Egypt
Downtown, Assiut, Egypt
Haram, Cairo, Egypt
Ahmedabad, Gujarat, India
Rohtak, Haryana, India
Bangalore, Karnataka, India
Chennai, Royapuram, India
Kolkata, West Bengal, India
Delhi, , India
Pondicherry, , India
Vadodara, , India
Johor Darul Takzim, Iskandar Puteri, Malaysia
Monterrey, Nuevo Leon, Mexico
Campina Grande Do Sul, , Brazil
Santa Cruz Do Sul, , Brazil
Los Yoses, San José, Costa Rica
Guayaquil, Guayas, Ecuador
Manta, Manabi, Ecuador
Quito, , Ecuador
Al Kasr Al Eini, Cairo, Egypt
El Matareya, Cairo, Egypt
El Nozha, Cairo, Egypt
Maadi, Cairo, Egypt
Ramses, Cairo, Egypt
Roxy, Cairo, Egypt
Agouza, Giza, Egypt
Faisal, Giza, Egypt
Kumasi, Ashanti Region, Ghana
Attica, Athens, Greece
Attiki, Athens, Greece
Chalkidiki, Nea Moudania, Greece
Lamia, , Greece
Thessaloniki, , Greece
Gujarat, Ahmedabad, India
Jambi, Telanaipura, Indonesia
Eldoret, , Kenya
Jalisco, Guadalajara, Mexico
Nuevo Leon, Guadalupe, Mexico
Queretaro, San Juan Del Río, Mexico
Lagos, , Nigeria
Dasmarinas, Cavite, Philippines
Marikina, Metro Manila, Philippines
Pasig, Metro Manila, Philippines
Antipolo, Rizal, Philippines
Cebu, , Philippines
Iloilo, , Philippines
Benoni, Johannesburg, South Africa
Durban, Kwazulu Natal, South Africa
Taoyuan City, , Taiwan
São Caetano Do Sul, , Brazil
Salvador, Bahia, Brazil
Fortaleza, Ceará, Brazil
Brasília, Distrito Federal, Brazil
Colatina, Espírito Santo (Es), Brazil
Poços De Caldas, Minas Gerais, Brazil
Teresina, Piauí (Pi), Brazil
Santa Cruz Do Sul, Rio Grande Do Sul (Rs), Brazil
Goiânia, State Of Goiás, Brazil
Joinville, State Of Santa Catarina, Brazil
Bragança Paulist, São Paulo, Brazil
São Caetano Do Sul, São Paulo, Brazil
Providencia, Santiago Metropolitan Region, Chile
Abidjan, , Côte D'ivoire
Wan Chai District, , Hong Kong
Sulaimani, , Iraq
Almaty, , Kazakhstan
Nairobi, , Kenya
Kuala Lumpur, Selangor, , Malaysia
León, Guanajuato, Mexico
Ciudad De México, , Mexico
Colonia Doctores Neighborhood, , Mexico
Iztapalapa, , Mexico
Mexico, , Mexico
Gwagwalada, , Nigeria
Kano, , Nigeria
Florida, , South Africa
Umhlanga, , South Africa
Niaosong Dist, Kaohsiung, Taiwan
Changhua City, , Taiwan
Kaohsiung City, , Taiwan
Taichung City, , Taiwan
Dnipro, Dnipropetrovsk Oblast, Ukraine
Kharkiv, Kharkiv Oblast, Ukraine
Kyiv, Kyiv Oblast, Ukraine
Vinnytsia, Vinnytsia Oblast, Ukraine
Lutsk, Volyn Oblast, Ukraine
Uzhhorod, Zakarpattia Oblast, Ukraine
Zaporizhzhia, Zaporizhzhia Oblast, Ukraine
Fortaleza, , Brazil
Colatina, , Brazil
Teresina, , Brazil
Goiânia, , Brazil
Bragança Paulist, , Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials